XRHealth has announced it raised $10 million to expand VR healthcare in the metaverse. Investors include HTC, AARP, and Bridges Israel impact investment fund. According to a recent McKinsey report, virtual healthcare will potentially be a quarter trillion-dollar market.
“Together, we’re taking the next step in growing the open ecosystem and providing greater access to care while reducing costs. Said HTC Co-founder and chairwoman Cher Wang, “Interoperability is key and working with XRHealth opens a world of possibilities in using technology for good.”
XRHealth and Virtual Treatment
Virtual treatment rooms allow physicians to expand their business and improve patient access to care. Likewise, patients feel more at ease when engaging in therapy sessions from their homes. XRHealth feels it is leaving a considerable imprint on healthcare in the metaverse by expanding access to healthcare for patients around the globe. However, XRHealth isn’t the only healthcare metaverse platform available. Hekka Labs launched its healthcare ecosystem in January 2022.
“XRHealth is putting Virtual Clinics into users’ pockets at a critical time in the changing landscape of the medical delivery and the technology industry,” said Chief Executive Officer of XRHealth, Eran Orr, “We are leveraging these changes to create a new form of healthcare that is accessible at any time of day, from any location in the virtual environment of the metaverse, where treatment can be personalized and adjusted based on real-time analytics.”
The healthcare platform is CE and FDA registered and currently provides immersive healthcare experiences. Additionally, most major insurance providers cover the platform’s patient care.
“Widely covered by insurance providers, XRHealth’s virtual clinics inclusively improves access to quality care and enhances the efficacy of healthcare treatment,” said Managing Partner at Bridges Israel and member of the board at XRHealth, Gal Hayut, “As an impact-tech investor, we see the company’s growth, positive clinical results alongside high patients’ satisfaction as an indication of its tangible impact on patients’ wellbeing.”